Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Daito Pharmaceutical Co., Ltd. ( (JP:4577) ) has issued an update.
Daito Pharmaceutical Co., Ltd. announced the repurchase of 64,500 shares of its own common stock, amounting to 132,139,100 yen, as part of a previously approved buyback program. This strategic move underscores the company’s commitment to enhancing shareholder value and indicates a positive outlook on its financial position.
More about Daito Pharmaceutical Co., Ltd.
Daito Pharmaceutical Co., Ltd. operates in the pharmaceutical industry, primarily engaging in the development and sale of pharmaceutical products. It is listed on the Prime Market of the Tokyo Stock Exchange, implying a focus on high standards of corporate governance and operational efficiency.
YTD Price Performance: -0.67%
Average Trading Volume: 31,467
Technical Sentiment Consensus Rating: Buy
Current Market Cap: Yen31.85B
See more data about 4577 stock on TipRanks’ Stock Analysis page.
Trending Articles:
- “…Overlook a Lack of Earnings Power”: UBS Analysts Target Intel Stock (NASDAQ:INTC), Stock Gains
- “…Significantly Extend the Reach and Lethality of our Fleet”: Boeing Stock (NYSE:BA) Slips Despite Successful MQ-25A Test
- “Direct Result of Your Feedback….” Microsoft Stock (NASDAQ:MSFT) Slips as The Option to Skip Updates Emerges